View Clinical Trial (Medical Research Study)
Trial Using Motivational Interviewing Positive Affect and Self-Affirmation in Hypertension (TRIUMPH)
| City: |
|
Bronx |
| State: |
|
New York |
| Zip Code: |
|
10451 |
| Conditions: |
|
Hypertension |
| Purpose: |
|
The primary aim of this study is to evaluate whether an intervention that combines positive
affect and self-affirmation with motivational interviewing (TRIUMPH) improves blood pressure
control compared to an educational/behavioral contract intervention at 12 months. We
hypothesize that a greater proportion of participants in the experimental arm of TRIUMPH
will have adequate blood pressure control as defined by Seventh Joint National Committee on
Detection, Evaluation and Treatment of Hypertension (JNC-7.)
|
| Study Summary: |
|
TRIUMPH is designed to build on the findings of our previous studies by combining positive
affect and self affirmation with motivational interviewing in order to increase blood
pressure control in community based practices that care for large numbers of hypertensive
black patients. Patients in both the educational and behavioral contract control group and
would receive a workbook, would make a behavioral contract, and a home blood pressure
monitor. The positive affect/self-affirmation group would receive the same components as the
control group. In addition the experimental group would receive a positive
affect/self-affirmation induction and motivational interviewing.
Both the control group and the experimental group would be followed at 2 month intervals.
The outcome blood pressure control in this group will be contrasted to the
knowledge/behavioral contract group. We hypothesize that we can increase the percent of
patients who have blood pressure control to 75%.
|
| Criteria: |
|
Inclusion Criteria:
- 18 years or older.
- Must be receiving care within the Renaissance Health Network for at least one year.
- Must have uncontrolled HTN defined as an average SBP>140 mmHg or DBP>90 mmHg on at
least two previous visits in the past year and be taking at least one
antihypertensive medication.
- Must self-identify as Black, or African American.
- Must have patient's physician to participate in the study.
Exclusion Criteria:
- Being deemed unable to comply with the study protocol (either self-selected or by
indicating during screening that he/she could not complete all requested tasks).
- Participation in other clinical trials.
- Diagnosis of cognitive dysfunction or significant psychiatric comorbidity.
|
| NCT ID: |
|
NCT01024933 |
| Primary Contact: |
|
Principal Investigator
Carla Boutin-Foster, MD
Weill Medical College of Cornell University
Carla Boutin-Foster, MD
Phone: 212-746-1607
Email: cboutin@med.cornell.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Bronx, New York 10451
United States
Carla Boutin-Foster, MD
Phone: 212-746-1607
Email: cboutin@med.cornell.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 19, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|